Next report date
Report period
Q1 2024
EPS estimate
−0.30EUR
Revenue estimate
3.91 MEUR
−1.605EUR
−93.48 MEUR
698.35 KEUR
43.14 M
About CELLECTIS
Sector
CEO
André Choulika
Headquarters
Paris
Website
Founded
1999
ISIN
FR0010425595
FIGI
BBG00JPR2KV0
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0WA2 is 2.440 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange CELLECTIS EUR0.05 stocks are traded under the ticker 0WA2.
CELLECTIS EUR0.05 is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
0WA2 stock is 0% volatile and has beta coefficient of 5.47. Check out the list of the most volatile stocks — is CELLECTIS EUR0.05 there?
0WA2 earnings for the last quarter are −0.29 EUR per share, whereas the estimation was −0.39 EUR resulting in a 25.66% surprise. The estimated earnings for the next quarter are −0.18 EUR per share. See more details about CELLECTIS EUR0.05 earnings.
CELLECTIS EUR0.05 revenue for the last quarter amounts to 1.54 M EUR despite the estimated figure of 3.34 M EUR. In the next quarter revenue is expected to reach 1.66 M EUR.
Yes, you can track CELLECTIS EUR0.05 financials in yearly and quarterly reports right on TradingView.
0WA2 stock has risen by 2.85% compared to the previous week, the month change is a 2.63% fall, over the last year CELLECTIS EUR0.05 has showed a 39.27% increase.
0WA2 net income for the last quarter is −39.86 M EUR, while the quarter before that showed −16.07 M EUR of net income which accounts for −148.01% change. Track more CELLECTIS EUR0.05 financial stats to get the full picture.
Today CELLECTIS EUR0.05 has the market capitalization of 174.71 M, it has increased by 4.03% over the last week.
No, 0WA2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0WA2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELLECTIS EUR0.05 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CELLECTIS EUR0.05 technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CELLECTIS EUR0.05 stock shows the sell signal. See more of CELLECTIS EUR0.05 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CELLECTIS EUR0.05 future price: according to them, 0WA2 price has a max estimate of 9.35 EUR and a min estimate of 2.81 EUR. Read a more detailed CELLECTIS EUR0.05 forecast: see what analysts think of CELLECTIS EUR0.05 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELLECTIS EUR0.05 EBITDA is −82.29 M EUR, and current EBITDA margin is −11.67 K%. See more stats in CELLECTIS EUR0.05 financial statements.